Mike Hollan

The Health Cube will increase remote and virtual care options for populations living in remote areas.

BrandShield states that it has identified sites selling counterfeit versions of Wegovy and Ozempic, among other drugs.

Butta discusses how new technologies are being implemented in at-home devices.

Tava’s network of therapists will be added to Health Advocate’s existing network.

Damien Bailly, president of established markets at Astellas, discusses why partnerships and collaborations are a critical organizational—and wider ecosystem—imperative in ensuring that patients have access to the medicines they need.

Users will be able to access DeepScribe’s documentation platform through AWS.

The program is designed to tackle issues related to the high cost of prescription medication.

This facility is the first of four facilities to be built in the area.

The meeting is scheduled for May in Switzerland.

The vaccine is already approved for older adults.

The move is part of Synaptogenix’s partnership with Cannasoul.

The pharmacy will now operate as Saveway Compounding Pharmacy, a Myonex company.

These expansions include a new product, along with improvements to existing products.

The move is intended to improve access to care at these critical sites.

FDA’s program will provide guidance to the development of the company’s Delphi-MD technology.

The technology will reportedly improve consumer engagement.

The vaccine can reportedly prevent infection from a fungal source that impacts both people and dogs.

The two programs will be offered to students and CVS interns.

Otsuka and Click Therapeutics co-developed Rejoyn, a digital therapeutic for MDD.

Erickson discusses his work developing unique, targeted autologous and allogeneic T cell therapeutics.

The two company’s will provide consumers with a platform where they can compare drug prices.

Mills is working in leadership in two roles, one of which puts her on the forefront of the genomic medicine movement.

The two organizations will work together to advocate for better health outcomes for children and families in North Carolina.

The network will work with DiRx and MakoRX.

The news comes less than a year after Pfizer announced that IPG would handle this role.

The study used technology developed by a variety of companies, including RYLTI.

Marquez discusses the results of a recent survey about how elements of the industry are reacting to a post remote-work world.

The bill would remove financial for genetic testing determined to be clinically appropriate.

Both products are designed to help radiologists.

The conversation took place during the Veeva R&D Summit in Boston.